Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
5
×
national
national blog main
national top stories
5
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
eli lilly
biogen
cancer
drug prices
medicaid
novartis
aduro biotech
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
celgene
deals
What
price
5
×
drug
bio
companies
plan
roundup
year
administration
airport
alzheimer’s
angry
annual
answer
anti
apocalypse
approval
away
beds
benefited
biogen’s
biopharmaceutical
celgene
convo
days
democratic
dems
despite
different
discontent
drugs
earlier
election
fail
failures
fallout
fear
gene
gone
high
home
Language
unset
Current search:
medicare
×
" national top stories "
×
price
×
" raleigh-durham top stories "
×
@xconomy.com
5 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More